{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:36:26Z","timestamp":1792373786918,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016819","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtha.2025.06.033","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:52:13Z","timestamp":1752681133000},"page":"3540-3560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the combined effect of antifibrinolytics and estrogen on the risk of thromboembolism: a scoping review"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0331-4450","authenticated-orcid":false,"given":"Danielle","family":"Meschino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace H.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fralick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.06.033_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/hematology.2022000391","article-title":"What have we learned about the patient\u2019s experience of von Willebrand disease? A focus on women","volume":"2022","author":"VanderMeulen","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.06.033_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib3","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.jogc.2018.03.007","article-title":"No. 292\u2014abnormal uterine bleeding in pre-menopausal women","volume":"40","author":"Singh","year":"2018","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.jtha.2025.06.033_bib4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jogc.2017.11.036","article-title":"No. 163\u2014gynaecological and obstetric management of women with inherited bleeding disorders","volume":"40","author":"Demers","year":"2018","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.jtha.2025.06.033_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1524-4733.2007.00168.x","article-title":"A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding","volume":"10","author":"Liu","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.jtha.2025.06.033_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2516.2010.02269.x","article-title":"The impact of menstrual disorders on quality of life in women with inherited bleeding disorders","volume":"16","author":"Kadir","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.06.033_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2007.01586.x","article-title":"Review of quality of life: menorrhagia in women with or without inherited bleeding disorders","volume":"14","author":"Shankar","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.06.033_bib8","series-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","first-page":"41","year":"2012"},{"key":"10.1016\/j.jtha.2025.06.033_bib9","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/j.jogc.2018.09.024","article-title":"No. 235\u2014active management of the third stage of labour: prevention and treatment of postpartum hemorrhage","volume":"40","author":"Leduc","year":"2018","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.jtha.2025.06.033_bib10","first-page":"CD000154","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","volume":"2","author":"Lethaby","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.06.033_bib11","first-page":"413","article-title":"Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety","volume":"4","author":"Leminen","year":"2012","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jtha.2025.06.033_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","author":"Lethaby","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.06.033_bib13","first-page":"CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"4","author":"Bryant-Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.06.033_bib14","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.06.033_bib15","first-page":"329","article-title":"Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis","volume":"16","author":"Franchini","year":"2018","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2025.06.033_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2018.02.008","article-title":"Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?","volume":"98","author":"Thorne","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.06.033_bib17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1701-2163(16)34746-6","article-title":"SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update","volume":"32","author":"Reid","year":"2010","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.jtha.2025.06.033_bib18","series-title":"Lysteda (Tranexamic acid modified-release tablets). FDA Approval Package","first-page":"1","year":"2013"},{"key":"10.1016\/j.jtha.2025.06.033_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0037-1616122","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.033_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"CRASH-2 trial collaborators","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.06.033_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib23","author":"Meschino"},{"key":"10.1016\/j.jtha.2025.06.033_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3889\/oamjms.2018.220","article-title":"Trend and causes of maternal mortality in a nigerian tertiary hospital: a 5-year retrospective study (2010-2014) at the university of calabar teaching hospital, Calabar, Nigeria","volume":"6","author":"Agan","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.jtha.2025.06.033_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18203\/2320-1770.ijrcog20190017","article-title":"Tranexamic acid in prevention of postpartum hemorrhage in elective cesarean section","volume":"8","author":"Shah","year":"2019","journal-title":"Int J Reprod Contraception, Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s11239-020-02141-4","article-title":"National trends in tranexamic acid use in the peripartum period, 2015\u20132019","volume":"50","author":"Ahmadzia","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.06.033_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3109\/14767058.2014.941283","article-title":"Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery","volume":"28","author":"Ahmed","year":"2015","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib28","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41598-023-30947-8","article-title":"Tranexamic acid for the prevention of postpartum haemorrhage: the TAPPH-1 pilot randomized trial and lessons learned for trials in Canadian obstetrics","volume":"13","author":"Alam","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.06.033_bib29","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1080\/14767058.2021.2019215","article-title":"The effect of prophylactic use of tranexamic acid for cesarean section","volume":"35","author":"Binyamin","year":"2022","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3109\/14767058.2015.1056731","article-title":"Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery","volume":"29","author":"Bouet","year":"2016","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.35755\/jmedassocthai.2023.03.13798","article-title":"Efficacy of preoperative intravenous tranexamic acid before cesarean section in placenta previa: a randomized double blind control trial","volume":"106","author":"Chaiyakarn","year":"2023","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.jtha.2025.06.033_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1076029618758956","article-title":"Standardized management protocol in severe postpartum hemorrhage: a single-center study","volume":"24","author":"Colucci","year":"2018","journal-title":"Clin Appl Thromb"},{"key":"10.1016\/j.jtha.2025.06.033_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2025.06.033_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bja.2022.08.033","article-title":"Tranexamic acid dose\u2013response relationship for antifibrinolysis in postpartum haemorrhage during caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study","volume":"129","author":"Ducloy-Bouthors","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtha.2025.06.033_bib35","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.21608\/ejhm.2018.12737","article-title":"Prevention of postpartum hemorrhage after vaginal delivery using tranexamic acid","volume":"73","author":"El-Garhy","year":"2018","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib36","first-page":"966","article-title":"Investigation of prophylactic effect of tranexamic acid in preventing postpartum hemorrhage in besat hospital in sanandaj. Pakistan J","volume":"15","author":"Farhadifar","year":"2021","journal-title":"Med Heal Sci"},{"key":"10.1016\/j.jtha.2025.06.033_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2015.11.022","article-title":"Renal cortical necrosis in postpartum hemorrhage: a case series","volume":"68","author":"Frimat","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jtha.2025.06.033_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0301-2115(03)00287-2","article-title":"Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial","volume":"112","author":"Gai","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jtha.2025.06.033_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/1658-354X.121077","article-title":"Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial","volume":"7","author":"Goswami","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.jtha.2025.06.033_bib40","first-page":"407","article-title":"Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study","volume":"30","author":"Gungorduk","year":"2013","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jtha.2025.06.033_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1213\/XAA.0000000000000535","article-title":"Aortoiliac thrombosis following tranexamic acid administration during urgent cesarean hysterectomy: a case report","volume":"9","author":"Hajmurad","year":"2017","journal-title":"A A Case Rep"},{"key":"10.1016\/j.jtha.2025.06.033_bib42","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.21608\/ejhm.2020.120453","article-title":"Efficacy of oxytocin infusion versus tranexamic acid infusion in controlling blood loss during elective lower segment caesarean section","volume":"81","author":"Elsaid","year":"2020","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","article-title":"Obstetric bleeding among women with inherited bleeding disorders: a retrospective study","volume":"22","author":"Hawke","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.06.033_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/B:CARD.0000033646.21346.e4","article-title":"Combined treatment with tranexamic acid and oral contraceptive pill causes coronary ulcerated plaque and acute myocardial infarction","volume":"18","author":"Iacobellis","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jtha.2025.06.033_bib45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12884-022-04462-z","article-title":"Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial","volume":"22","author":"Igboke","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jtha.2025.06.033_bib46","first-page":"19","article-title":"Prophylactic use of tranexamic acid on blood loss in Cesarean delivery: a randomized controlled- clinical trial","volume":"26","author":"Jafarbegloo","year":"2021","journal-title":"Trauma Monthly"},{"key":"10.1016\/j.jtha.2025.06.033_bib47","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1080\/14767058.2021.1888911","article-title":"Effects of tranexamic acid on the amount of bleeding following vaginal delivery and its adverse effects: a double-blind placebo controlled randomized clinical trial","volume":"35","author":"Kashanian","year":"2022","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5468\/ogs.2014.57.4.314","article-title":"Successful management of maternal factor VII deficiency in a cesarean section","volume":"57","author":"Lee","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.jtha.2025.06.033_bib49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/1471-0528.17445","article-title":"Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: a single-centre double-blind randomised controlled trial","volume":"130","author":"Lee","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2025.06.033_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jogc.2015.11.002","article-title":"Management of labour and delivery in a patient with acquired factor VII deficiency with inhibitor: a case report","volume":"38","author":"Matei","year":"2016","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.jtha.2025.06.033_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ajo.12262","article-title":"The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial","volume":"55","author":"Mirghafourvand","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijgo.2011.07.015","article-title":"Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery","volume":"115","author":"Movafegh","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101973","article-title":"Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: a placebo-controlled randomized clinical trial","volume":"50","author":"Naeiji","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jtha.2025.06.033_bib54","first-page":"23","article-title":"Role of intravenous tranexamic acid in reducing blood loss during caesarean delivery","volume":"29","author":"Nandal","year":"2022","journal-title":"Int Med J"},{"key":"10.1016\/j.jtha.2025.06.033_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3329\/bjog.v33i2.43564","article-title":"Prophylactic use of tranexamic acid during caesarean section in preventing postpartum haemorrhage-a prospective randomised double blind placebo controlled study","volume":"33","author":"Nargis","year":"2018","journal-title":"Bangladesh J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib56","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","article-title":"Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery","volume":"388","author":"Pacheco","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib57","article-title":"Bleeding versus clotting: a complex case of a large fibroid uterus causing menorrhagia and a DVT","volume":"2016","author":"Ramanan","year":"2016","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5958\/0976-5506.2015.00063.7","article-title":"Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study","volume":"6","author":"Ramesh","year":"2015","journal-title":"Indian J Public Health Res Dev"},{"key":"10.1016\/j.jtha.2025.06.033_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13224-016-0915-x","article-title":"Role of intravenous tranexamic acid on caesarean blood loss: a prospective randomised study","volume":"66","author":"Ray","year":"2016","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.jtha.2025.06.033_bib60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s13224-016-0856-4","article-title":"Role of tranexamic acid in reducing blood loss in vaginal delivery","volume":"66","author":"Roy","year":"2016","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.jtha.2025.06.033_bib61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/14767050802353580","article-title":"Efficacy of tranexamic acid in reducing blood loss after cesarean section","volume":"22","author":"Sekhavat","year":"2009","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib62","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"Sentilhes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib63","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-012-2624-8","article-title":"Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial","volume":"287","author":"Sent\u00fcrk","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib65","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1080\/14767058.2017.1418316","article-title":"The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial","volume":"32","author":"Shady","year":"2019","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.36129\/jog.34.01.06","article-title":"The effect of intravenous (IV) tranexamic acid plus buccal misoprostol on blood loss during and after cesarean delivery: a randomized double-blind study","volume":"34","author":"Shady","year":"2022","journal-title":"Italian J Gynaecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib67","first-page":"459","article-title":"Tranexamic acid in decreasing blood loss during and after cesarean section","volume":"23","author":"Shahid","year":"2014","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"10.1016\/j.jtha.2025.06.033_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/fjs.fjs_122_22","article-title":"Comparative study of oxytocin versus tranexamic acid and ethamsylate in preventing primary postpartum hemorrhage in women undergoing lower-segment cesarean section","volume":"55","author":"Singh","year":"2022","journal-title":"Formos J Surg"},{"key":"10.1016\/j.jtha.2025.06.033_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21608\/ejhm.2021.137140","article-title":"Prophylactic use of tranexamic acid in reducing blood loss during elective cesarean section","volume":"82","author":"Soliman","year":"2021","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jtha.2025.06.033_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.100933","article-title":"An update to tranexamic acid trends during the peripartum period in the United States, 2019 to 2021","volume":"5","author":"Sterling","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jtha.2025.06.033_bib71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijgo.2015.09.032","article-title":"Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery","volume":"133","author":"Sujata","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib72","first-page":"QC01","article-title":"Effectiveness of tranexamic acid for reducing postpartum blood loss in the first two hours after vaginal delivery: a randomised controlled trial","volume":"12","author":"Sujita","year":"2018","journal-title":"J Clin Diagnostic Res"},{"key":"10.1016\/j.jtha.2025.06.033_bib73","first-page":"558","article-title":"Role of tranexamic acid in reducing blood loss during and after caesarean section","volume":"14","author":"Tayyba","year":"2020","journal-title":"Pakistan J Med Heal Sci"},{"key":"10.1016\/j.jtha.2025.06.033_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00404-012-2593-y","article-title":"Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial","volume":"287","author":"Xu","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jtha.2025.06.033_bib75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1574884713666180507101002","article-title":"The effect of tranexamic acid on preventing post-partum hemorrhage due to uterine atony: a triple-blind randomized clinical trial","volume":"13","author":"Zargar","year":"2018","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.jtha.2025.06.033_bib76","series-title":"Tranexamic acid (Lysteda) approval package","year":"2011"},{"key":"10.1016\/j.jtha.2025.06.033_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18203\/2320-1770.ijrcog20190017","article-title":"Tranexamic acid in prevention of postpartum hemorrhage in elective cesarean section","volume":"8","author":"Shah","year":"2019","journal-title":"Int J Reprod Contracep Obstet Gynecol"},{"issue":"85","key":"10.1016\/j.jtha.2025.06.033_bib78","first-page":"e1","article-title":"Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women","volume":"225","author":"Ahmadzia","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib79","doi-asserted-by":"crossref","first-page":"S779","DOI":"10.1016\/j.ajog.2021.12.020","article-title":"LB 3: tranexamic acid for the prevention of obstetrical hemorrhage after cesarean delivery: a randomized controlled trial","volume":"226","author":"Pacheco","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.06.033_bib80","series-title":"Tranexamic acid in sodium chloride injection. FDA Approval Package","first-page":"1","year":"2010"},{"key":"10.1016\/j.jtha.2025.06.033_bib81","first-page":"238","article-title":"Tranexamic acid. Summary of product characteristics and package leaflet","volume":"21","year":"2021","journal-title":"Yearb Int Trib Law Sea\/Annu Trib Int du droit la mer"},{"key":"10.1016\/j.jtha.2025.06.033_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100882","article-title":"Oral tranexamic acid and thrombosis risk in women","volume":"35","author":"Meaidi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtha.2025.06.033_bib84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2021.06.006","article-title":"Concomitant use of combined hormonal contraceptives and antifibrinolytic agents for the management of heavy menstrual bleeding: a practice pattern survey","volume":"204","author":"Lim","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.06.033_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.06.033_bib86","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.06.033_bib87","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.06.033_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.033_bib89","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2025.06.033_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.06.033_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102389","article-title":"Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use","volume":"8","author":"VanderMeulen","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.033_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2025.06.033_bib93","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1182\/blood-2022-167945","article-title":"Take control. Period.\u2014interactive patient education website enhances adherence to tranexamic acid and iron supplementation in women with heavy menstrual bleeding","volume":"140","author":"Norman","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.033_bib94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijgo.13028","article-title":"Postpartum hemorrhage care bundles to improve adherence to guidelines: a WHO technical consultation","volume":"148","author":"Althabe","year":"2020","journal-title":"Int J Gynecol Obstet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:11:29Z","timestamp":1778818289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":92,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538783625004222"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.033","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the combined effect of antifibrinolytics and estrogen on the risk of thromboembolism: a scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}